Boehringer Ingelheim to help accelerate 1ST's "PetYeti" online appointment booking solution sales to their 1200 VetPlus member practices.
1st Group has entered into a strategic partnership with a major, global pharmaceutical company, Boehringer Ingleheim (BI) commencing December 2018
- BI's highly effective over 30 strong infield sales team will actively promote the adoption of PetYeti, 1st Group's convenient and easy to use, digital online booking platform to over 1200 vet practice members of its successful VetPlus program.
- Based on known published pricing of PetYeti, this could yield 1ST up to $120k per month in new subscription revenues if all VetPlus member practices adopted the new service
Commercial sales are expected to start in February 2019, generating recurring monthly revenues, with scope for additional product cross-sell
BI will provide support for sales and marketing costs for the program and subsidise the adoption costs of PetYeti for all its member practices who take up the service
BI's infield sales team has a proven track record in driving the adoption of VetPlus sponsored products, such as PetYeti, across its member base
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).
